Status:
TERMINATED
Visualization Tool for Investigation of Breast Lesions
Lead Sponsor:
Sunnybrook Health Sciences Centre
Conditions:
Breast Lesions
Eligibility:
FEMALE
21-80 years
Brief Summary
Magnetic resonance imaging (MRI) is commonly used for the detection of breast lesions in genetically high-risk women due to its high sensitivity. As non-cancerous conditions including normal changes d...
Eligibility Criteria
Inclusion
- Patients with MRI-identified lesions that cannot be visualized under the second-look ultrasound examination, and who will undergo the recommended unilateral MRI follow-up.
Exclusion
- US-visible lesion.
- Any contraindications to MRI (e.g., pacemakers, metal implants).
- Any contraindications to US imaging.
- Pregnancy.
- Claustrophobia.
- Inability to lie still for 45 minutes-1 hour.
- In excess of 250 pounds.
- Incapability to provide informed consent.
Key Trial Info
Start Date :
July 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2011
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT00934297
Start Date
July 1 2009
End Date
July 1 2011
Last Update
July 28 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada, M4N 3M5